Daniel Eiras
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Respiratory viral infections research 6
- Trypanosoma species research and implications 2
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Co-authors
- David P. Calfee (6 shared papers)E. Yoko Furuya (6 shared papers)Brian Nelson (3 shared papers)Angela Loo (3 shared papers)Christine J. Kubin (3 shared papers)Henry W. Murray (2 shared papers)Laura A. Kirkman (2 shared papers)Angela Gomez‐Simmonds (2 shared papers)
- Journals
- Open Forum Infectious Diseases (6 papers)Antimicrobial Agents and Chemotherapy (3 papers)Infection Control and Hospital Epidemiology (2 papers)Clinical Infectious Diseases (1 paper)Hematological Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Daniel Eiras
16 papers receiving 394 citations
Daniel Eiras's Hit Papers
Peers
Comparison fields: 5 of 52
- Applied Microbiology and Biotechnology 66
- Molecular Medicine 139
- Pharmacology 59
- Hepatology 33
- Pharmacology 71
Countries citing papers authored by Daniel Eiras
This map shows the geographic impact of Daniel Eiras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Eiras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Eiras more than expected).
Fields of papers citing papers by Daniel Eiras
This network shows the impact of papers produced by Daniel Eiras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Eiras. The network helps show where Daniel Eiras may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Eiras, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 72 | |
| 2 | 2015 | 69 | |
| 3 | 2007 | 69 | |
| 4 | 2018 | 49 | |
| 5 | 2015 | 47 | |
| 6 | 2016 | 29 | |
| 7 | Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons Hit paper breakdown → | 2025 | 19 |
| 8 | 2018 | 18 | |
| 9 | 2010 | 11 | |
| 10 | 2020 | 5 | |
| 11 | 2015 | 3 | |
| 12 | 2015 | 2 | |
| 13 | 2014 | 2 | |
| 14 | 2025 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2016 | 1 | |
| 17 | 2023 | 0 | |
| 18 | 2024 | 0 |
About Daniel Eiras
Daniel Eiras is a scholar working on Epidemiology, Pharmacology, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Psychiatry and Mental health, having authored 18 papers that have together received 398 indexed citations. Recurring topics across this work include Respiratory viral infections research (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Infection Control and Ventilation (3 papers), Epilepsy research and treatment (3 papers), Trypanosoma species research and implications (2 papers), Antibiotic Use and Resistance (2 papers), Viral Infections and Immunology Research (2 papers) and Research on Leishmaniasis Studies (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (66 citations), Molecular Medicine (139 citations), Pharmacology (59 citations), Hepatology (33 citations) and Pharmacology (71 citations). Daniel Eiras has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include David P. Calfee, E. Yoko Furuya, Brian Nelson, Angela Loo, Christine J. Kubin, Henry W. Murray, Laura A. Kirkman, Angela Gomez‐Simmonds, Michael J. Satlin and Stephen G. Jenkins. Their work appears in journals such as Open Forum Infectious Diseases, Antimicrobial Agents and Chemotherapy, Infection Control and Hospital Epidemiology, Clinical Infectious Diseases and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.